CD34 ⁺ cell–derived fibroblast-macrophage cross-talk drives limb ischemia recovery through the OSM-ANGPTL signaling axis

The study explores the role of CD34+ cell-derived fibroblasts in limb ischemia recovery, emphasizing their interaction with macrophages through the OSM-ANGPTL signaling axis. Using both murine models and human samples from 8 patients with peripheral artery disease (PAD), researchers identified proregenerative fibroblasts that respond to macrophage-produced OSM signals, promoting angiogenesis and tissue regeneration. The study highlights the potential of targeting these fibroblast-macrophage interactions for therapeutic strategies in ischemic diseases, as current treatments have limited efficacy. Despite limitations such as small sample size and gender bias, the findings provide insights into cellular mechanisms of muscle repair and suggest new avenues for PAD treatment.